A citation-based method for searching scientific literature

Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, Ranjit Manchanda, Matthew Burnell, Philip Badman, Richard Hadwin, Ivana Rizzuto, Elizabeth Benjamin, Naveena Singh, D Gareth Evans, Diana M Eccles, Andy Ryan, Robert Liston, Anne Dawnay, Jeremy Ford, Richard Gunu, James Mackay, Steven J Skates, Usha Menon, Ian J Jacobs. J Clin Oncol 2017
Times Cited: 72







List of co-cited articles
735 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection.
Tyler H Tate, Brenda Baggett, Photini F S Rice, Jennifer Watson Koevary, Gabriel V Orsinger, Ariel C Nymeyer, Weston A Welge, Kathylynn Saboda, Denise J Roe, Kenneth D Hatch,[...]. J Biomed Opt 2016
10
10

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutated patients: An evidence-based approach on what women should know.
F De Felice, C Marchetti, S M Boccia, A Romito, C M Sassu, M G Porpora, L Muzii, V Tombolini, P Benedetti Panici. Cancer Treat Rev 2017
10
10

The Origin of Ovarian Cancer Species and Precancerous Landscape.
Ie-Ming Shih, Yeh Wang, Tian-Li Wang. Am J Pathol 2021
8
12

Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study.
C Bethan Powell, Ramey D Littell, Charles N Landen, Sharmila Pramanik, Isabella C Hamilton, Elizabeth J Suh-Burgmann. Gynecol Oncol 2020
1
100

Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Hiroyasu Kashima, Ren-Chin Wu, Yihong Wang, Abdulrahman K Sinno, Tsutomu Miyamoto, Tanri Shiozawa, Tian-Li Wang, Amanda N Fader, Ie-Ming Shih. Gynecol Oncol 2015
27
3

Assessing tubal damage.
Madhuri Patil. J Hum Reprod Sci 2009
20
5

A comparison of ovarian cancer mortality in women with BRCA1 mutations undergoing annual ultrasound screening or preventive oophorectomy.
Jacek Gronwald, Jan Lubinski, Tomasz Huzarski, Cezary Cybulski, Janusz Menkiszak, Monika Siołek, Małgorzata Stawicka, Ping Sun, Shana J Kim, Joanne Kotsopoulos,[...]. Gynecol Oncol 2019
4
25

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.
Angela R Bradbury, Comfort N Ibe, James J Dignam, Shelly A Cummings, Marion Verp, Melody A White, Grazia Artioli, Laura Dudlicek, Olufunmilayo I Olopade. Genet Med 2008
66
1

Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry.
Michael A Campitelli, Anna M Chiarelli, Lucia Mirea, Lindsay Stewart, Gord Glendon, Paul Ritvo, Irene L Andrulis, Julia A Knight. Eur J Cancer Prev 2011
16
6

Large-Scale Implementation of Structured Reporting of Adnexal Masses on Ultrasound.
Elizabeth J Suh-Burgmann, Tracy Flanagan, Nina Lee, Todd Osinski, Cliff Sweet, Margaret Lynch, Marianna Caponigro, Jaysheel Mehta, Mubarika Alavi, Lisa J Herrinton. J Am Coll Radiol 2018
9
11

Prospective Validation of a Standardized Ultrasonography-Based Ovarian Cancer Risk Assessment System.
Elizabeth Suh-Burgmann, Tracy Flanagan, Todd Osinski, Mubarika Alavi, Lisa Herrinton. Obstet Gynecol 2018
11
9

The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome.
J M Helder-Woolderink, G H De Bock, R H Sijmons, H Hollema, M J E Mourits. Gynecol Oncol 2013
15
6

Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS).
Ranjit Manchanda, Ertan Saridogan, Ahmed Abdelraheim, Michelle Johnson, Adam N Rosenthal, Elizabeth Benjamin, Carol Brunell, Lucy Side, Sue Gessler, Ian Jacobs,[...]. Arch Gynecol Obstet 2012
17
5

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
Elena M Stoffel, Pamela B Mangu, Stephen B Gruber, Stanley R Hamilton, Matthew F Kalady, Michelle Wan Yee Lau, Karen H Lu, Nancy Roach, Paul J Limburg. J Clin Oncol 2015
175
1

Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome.
Akriti Dewanwala, Anu Chittenden, Margery Rosenblatt, Rowena Mercado, Judy E Garber, Sapna Syngal, Elena M Stoffel. Fam Cancer 2011
14
7

European guidelines from the EHTG and ESCP for Lynch syndrome: an updated third edition of the Mallorca guidelines based on gene and gender.
T T Seppälä, A Latchford, I Negoi, A Sampaio Soares, R Jimenez-Rodriguez, L Sánchez-Guillén, D G Evans, N Ryan, E J Crosbie, M Dominguez-Valentin,[...]. Br J Surg 2020
17
5

Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Heikki J Järvinen, Laura Renkonen-Sinisalo, Katja Aktán-Collán, Päivi Peltomäki, Lauri A Aaltonen, Jukka-Pekka Mecklin. J Clin Oncol 2009
177
1

Vaginal and Laparoscopic hysterectomy as an outpatient procedure: A systematic review.
Suzanne J Dedden, Peggy M A J Geomini, Judith A F Huirne, Marlies Y Bongers. Eur J Obstet Gynecol Reprod Biol 2017
25
4

Hysteroscopic findings in women at risk of HNPCC. Results of a prospective observational study.
Fabrice Lécuru, Ulrike Metzger, Catherine Scarabin, Marie Aude Le Frère Belda, Sylviane Olschwang, Pierre Laurent Puig. Fam Cancer 2007
14
7


Complications in operative hysteroscopy - is prevention possible?
Mee Kristine Aas-Eng, Anton Langebrekke, Gernot Hudelist. Acta Obstet Gynecol Scand 2017
12
8

Pain evaluation during gynaecological surveillance in women with Lynch syndrome.
Jorien Helder-Woolderink, Geertruida de Bock, Harry Hollema, Magda van Oven, Marian Mourits. Fam Cancer 2017
6
16

Lynch syndrome for the gynaecologist.
Neil Aj Ryan, Raymond Ft McMahon, Neal C Ramchander, Mourad W Seif, D Gareth Evans, Emma J Crosbie. Obstet Gynaecol 2021
2
50

Long-term complications of office hysteroscopy: analysis of 1028 cases.
T C van Kerkvoorde, S Veersema, A Timmermans. J Minim Invasive Gynecol 2012
16
6

Factors associated with decision-making on prophylactic hysterectomy and attitudes towards gynecological surveillance among women with Lynch syndrome (LS): a descriptive study.
Mari H Kalamo, J U Mäenpää, T T Seppälä, J P Mecklin, H Huhtala, K Sorvettula, K Pylvänäinen, S Staff. Fam Cancer 2020
3
33

Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation.
S Stuckless, J Green, L Dawson, B Barrett, M O Woods, E Dicks, P S Parfrey. Clin Genet 2013
24
4

Complications of hysteroscopy: a prospective, multicenter study.
F W Jansen, C B Vredevoogd, K van Ulzen, J Hermans, J B Trimbos, T C Trimbos-Kemper. Obstet Gynecol 2000
198
1

Safety of hormone replacement therapy following risk-reducing salpingo-oophorectomy: systematic review of literature and guidelines.
R F M Vermeulen, C M Korse, G G Kenter, M M A Brood-van Zanten, M van Beurden. Climacteric 2019
11
9


Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback.
G P Browman, T E Newman, E A Mohide, I D Graham, M N Levine, K I Pritchard, W K Evans, J A Maroun, D I Hodson, M S Carey,[...]. J Clin Oncol 1998
80
1

Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.
Ying Chen, Elizabeth Bancroft, Sue Ashley, Audrey Arden-Jones, Sarah Thomas, Susan Shanley, Sibel Saya, Emma Wakeling, Rosalind Eeles. Fam Cancer 2014
2
50

The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review.
Tasneem Siyam, Sue Ross, Sandra Campbell, Dean T Eurich, Nesé Yuksel. BMC Womens Health 2017
11
9

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study.
K N Gaarenstroom, B van der Hiel, R A E M Tollenaar, G R Vink, F W Jansen, C J van Asperen, G G Kenter. Int J Gynecol Cancer 2006
39
2

Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests.
Marielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, Fiona Lennard, Paul Pharoah, Ian Jacobs, Ann Ward, Desmond Pj Barton, Thomas Ej Ind, John H Shepherd,[...]. Hered Cancer Clin Pract 2011
4
25

RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
Emma Nolan, François Vaillant, Jane E Visvader, Geoffrey J Lindeman. J Natl Cancer Inst 2017
6
16

The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.
G P Browman, M N Levine, E A Mohide, R S Hayward, K I Pritchard, A Gafni, A Laupacis. J Clin Oncol 1995
337
1

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
1

AGREE II: advancing guideline development, reporting and evaluation in health care.
Melissa C Brouwers, Michelle E Kho, George P Browman, Jako S Burgers, Francoise Cluzeau, Gene Feder, Béatrice Fervers, Ian D Graham, Jeremy Grimshaw, Steven E Hanna,[...]. CMAJ 2010
1

The National Cancer Institute Early Detection Research Network: Two Decades of Progress.
Robert C Bast, Sudhir Srivastava. Cancer Epidemiol Biomarkers Prev 2020
1
100

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Naveena Singh, Andy Ryan, Chloe Karpinskyj, Giulia Carlino, Julie Taylor, Susan K Massingham, Maria Raikou,[...]. Lancet 2021
11
9

A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin.
Dengxuan Fan, Hailing Yang, Weiqun Mao, Philip J Rask, Lan Pang, Congjian Xu, Hariprasad Vankayalapat, Ahmed A Ahmed, Robert C Bast, Zhen Lu. Cancers (Basel) 2021
1
100


Biomarkers and Strategies for Early Detection of Ovarian Cancer.
Robert C Bast, Zhen Lu, Chae Young Han, Karen H Lu, Karen S Anderson, Charles W Drescher, Steven J Skates. Cancer Epidemiol Biomarkers Prev 2020
10
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.